Thursday, June 9, 2022

FDA: Taking Comments on ctDNA Diagnostics in Cancer

I don't think I've flagged this - 

On May 2, 2022, FDA released a draft guidance on use of ctDNA in early tumors.  Comment is open til the end of the month.

Home page at FDA here:

Comment page at

Note that  FDA previously produced draft and final documents on minimal residual disease in hematopoietic cancers:  here.